Sex Steroids and Plasma Lipoprotein Levels in Healthy Women: The Importance of Androgens in the Estrogen-Deficient State

Metabolism: Clinical and Experimental

Volumn 53, Issue 2, 2004, Pages 187-192

  Van Beek, André P ^a   De Ruijter Heijstek, Florianne C ^a   Jansen, Hans ^a   Erkelens, D Willem ^a   De Bruin, Tjerk W A ^a  

^a Department of Internal Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTROGEN; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0842349498     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.022     Document Type: Article

References (37)

1. Gordon T, Kannel WB, Hjortland MC, et al: Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 89:157-161, 1978
2. van der Schouw YT, van der Graaf Y, Steyerberg EW, et al: Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718, 1996
3. Crook D, Seed M: Endocrine control of plasma lipoprotein metabolism: Effects of gonadal steroids. Baillieres Clin Endocrinol Metab 4:851-875, 1990
4. Bass KM, Newschaffer CJ, Klag MJ, et al: Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 153:2209-2216, 1993
5. Kannel WB: Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am Heart J 114:413-419, 1987
6. Austin MA: Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11:2-14, 1991
7. Lindquist O, Bengtsson C: Serum lipids, arterial blood pressure and body weight in relation to the menopause: Results from a population study of women in Goteborg, Sweden. Scand J Clin Lab Invest 40:629-636, 1980
8. Hjortland MC, McNamara PM, Kannel WB: Some atherogenic concomitants of menopause: The Framingham Study. Am J Epidemiol 103:304-311, 1976
9. Matthews KA, Meilahn E, Kuller LH, et al: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646, 1989
10. Van Beek AP, Ruijter-Heijstek FC, Erkelens DW, et al: Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 19:2737-2741, 1999
11. Walsh BW, Schiff I, Rosner B, et al: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204, 1991
12. Sacks FM, Walsh BW: Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 5:236-240, 1994
13. Gevers Leuven JA: Sex steroids and lipoprotein metabolism. Pharmacol Ther 64:99-126, 1994
14. Redgrave TG, Roberts DC, West CE: Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65:42-49, 1975
15. Jansen H, Hop W, van Tol A, et al: Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis 107:45-54, 1994
16. Westerveld HT, Kock LA, van Rijn HJ, et al: 17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 80:249-253, 1995
17. Nanjee MN, Wheeler MJ: Plasma free testosterone - Is an index sufficient? Ann Clin Biochem 22:387-390, 1985
18. Bjorntorp P: Androgens, the metabolic syndrome, and non-insulin-dependent diabetes mellitus. Ann NY Acad Sci 676:242-252, 1993
19. Wild RA, Applebaum-Bowden D, Demers LM, et al: Lipoprotein lipids in women with androgen excess: Independent associations with increased insulin and androgen. Clin Chem 36:283-289, 1990
20. Taskinen MR: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 6:153-160, 1995
21. Despres JP, Marette A: Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 5:274-289, 1994
22. Davis SR, Burger HG: Use of androgens in postmenopausal women. Curr Opin Obstet Gynecol 9:177-180, 1997
23. Wolfe BM, Barrett PH, Laurier L, et al: Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. J Lipid Res 41:368-375, 2000
24. Tam SP, Archer TK, Deeley RG: Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: Mechanism of antagonism by testosterone. Proc Natl Acad Sci USA 83:3111-3115, 1986
25. Bernini GP, Sgro M, Moretti A, et al: Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84:2008-2012, 1999
26. Barrett-Connor E, Goodman-Gruen D: Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 311:1193-1196, 1995
27. Phillips GB, Pinkernell BH, Jing TY: Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17:695-701, 1997
28. Haffner SM, Valdez RA: Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin. Am J Med 98:40S-47S, 1995 (suppl)
29. Davis SR, Burger HG: Clinical review 82: Androgens and the postmenopausal woman. J Clin Endocrinol Metab 81:2759-2763, 1996
30. Vatalas IA, Dionyssiou-Asteriou A: Adrenal C19 steroids and serum lipoprotein levels in healthy men. Nutr Metab Cardiovasc Dis 11:388-393, 2001
31. Wolfe BM, Huff MW: Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women. J Clin Invest 83:40-45, 1989
32. Wolfe BM, Huff MW: Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women. J Clin Invest 92:456-461, 1993
33. Tikkanen MJ, Kuusi T, Nikkila EA, et al: Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen. Studies on the physiological role of hepatic endothelial lipase. FEBS Lett 181:160-164, 1985
34. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 6:291-305, 1995
35. van Barlingen HH, Kock LA, de Man FH, et al: In vitro lipolysis of human VLDL: Effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. Atherosclerosis 121:75-84, 1996
36. Croston GE, Milan LB, Marschke KB, et al: Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 138:3779-3786, 1997
37. Nanjee MN, Koritnik DR, Thomas J, et al: Hormonal determinants of apolipoprotein B,E receptor expression in human liver. Positive association of receptor expression with plasma estrone concentration in middle-aged/elderly women. Biochim Biophys Acta 1046:151-158, 1990